These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8671599)

  • 1. IgM natural antibody against an asialo-oligosaccharide, gangliotetraose (Gg4), sensitizes HIV-I infected cells for cytolysis by homologous complement.
    Wu X; Okada N; Iwamori M; Okada H
    Int Immunol; 1996 Jan; 8(1):153-8. PubMed ID: 8671599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of IgM antibodies which sensitize HIV-1-infected cells to cytolysis by homologous complement in long-term survivors of HIV infection.
    Okada N; Wu X; Okada H
    Microbiol Immunol; 1997; 41(4):331-6. PubMed ID: 9159407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric human/murine monoclonal IgM antibodies to HIV-1 Nef antigen expressed on chronically infected cells.
    Kawai M; He L; Kawamura T; Omoto S; Fujii YR; Okada N
    Microbiol Immunol; 2003; 47(3):247-53. PubMed ID: 12725296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement-mediated anti-HIV-1 effect induced by human IgM monoclonal antibody against ganglioside GM2.
    Wu X; Okada N; Momota H; Irie RF; Okada H
    J Immunol; 1999 Jan; 162(1):533-9. PubMed ID: 9886430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-dependent complement-mediated cytotoxicity in sera from patients with HIV-1 infection is controlled by CD55 and CD59.
    Schmitz J; Zimmer JP; Kluxen B; Aries S; Bögel M; Gigli I; Schmitz H
    J Clin Invest; 1995 Sep; 96(3):1520-6. PubMed ID: 7544808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of the membrane inhibitor of complement-mediated cytolysis CD59 on T-lymphocytes of HIV-infected patients.
    Weiss L; Okada N; Haeffner-Cavaillon N; Hattori T; Faucher C; Kazatchkine MD; Okada H
    AIDS; 1992 Apr; 6(4):379-85. PubMed ID: 1377473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human IgM monoclonal antibodies reactive with HIV-1-infected cells generated using a trans-chromosome mouse.
    Okada N; Yin S; Asai S; Kimbara N; Dohi N; Hosokawa M; Wu X; Okada H
    Microbiol Immunol; 2005; 49(5):447-59. PubMed ID: 15905607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement-mediated cytolysis and azidothymidine are synergistic in HIV-1 suppression.
    Okada H; Wu X; Okada N
    Int Immunol; 1998 Jan; 10(1):91-5. PubMed ID: 9488159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of HIV-1 infectivity through an innate mechanism involving naturally occurring IgM anti-leukocyte autoantibodies.
    Lobo PI; Schlegel KH; Yuan W; Townsend GC; White JA
    J Immunol; 2008 Feb; 180(3):1769-79. PubMed ID: 18209074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection.
    Montefiori DC; Cornell RJ; Zhou JY; Zhou JT; Hirsch VM; Johnson PR
    Virology; 1994 Nov; 205(1):82-92. PubMed ID: 7526538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue distribution of HRF20, a novel factor preventing the membrane attack of homologous complement, and its predominant expression on endothelial cells in vivo.
    Nose M; Katoh M; Okada N; Kyogoku M; Okada H
    Immunology; 1990 Jun; 70(2):145-9. PubMed ID: 1695609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human IgM monoclonal antibody to ganglioside GM2 and complement suppress virus propagation in ex vivo cultures of lymphocytes from HIV-1 infected patients.
    Okada N; Wu X; Mizokami M; Irie RF; Okada H
    Microbiol Immunol; 1999; 43(7):723-7. PubMed ID: 10529115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The IgM antibody level against ganglioside GM2 correlates to the disease status of HIV-1-infected patients.
    Wu X; Okada N; Goto M; Iwamoto A; Okada H
    Microbiol Immunol; 2000; 44(5):405-10. PubMed ID: 10888361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative complement pathway-mediated myeloid cell cytotoxicity: repertoire of membrane factors participating in regulation of C3 deposition and cytolysis.
    Matsumoto M; Sugita Y; Seya T
    Eur J Immunol; 1991 Aug; 21(8):1787-92. PubMed ID: 1714391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic surface expression of SWAP-70 on HIV-1 infected T cells.
    Kimbara N; Dohi N; Miyamoto M; Asai S; Okada H; Okada N
    Microbiol Immunol; 2006; 50(3):235-42. PubMed ID: 16547421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane attack complex of complement and 20 kDa homologous restriction factor (CD59) in myocardial infarction.
    Tada T; Okada H; Okada N; Tateyama H; Suzuki H; Takahashi Y; Eimoto T
    Virchows Arch; 1997 Apr; 430(4):327-32. PubMed ID: 9134044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockage of CD59 Function Restores Activities of Neutralizing and Nonneutralizing Antibodies in Triggering Antibody-Dependent Complement-Mediated Lysis of HIV-1 Virions and Provirus-Activated Latently Infected Cells.
    Yang K; Lan J; Shepherd N; Hu N; Xing Y; Byrd D; Amet T; Jewell C; Gupta S; Kounga C; Gao J; Yu Q
    J Virol; 2015 Sep; 89(18):9393-406. PubMed ID: 26136568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human IgM monoclonal proteins that bind 3-fucosyllactosamine, asialo-GM1, and GM1.
    Marcus DM; Perry L; Gilbert S; Preud'homme JL; Kyle R
    J Immunol; 1989 Nov; 143(9):2929-32. PubMed ID: 2572647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bactericidal Immunity to Salmonella in Africans and Mechanisms Causing Its Failure in HIV Infection.
    Goh YS; Necchi F; O'Shaughnessy CM; Micoli F; Gavini M; Young SP; Msefula CL; Gondwe EN; Mandala WL; Gordon MA; Saul AJ; MacLennan CA
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004604. PubMed ID: 27057743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of HRF20, a regulatory molecule of complement activation, on peripheral blood mononuclear cells.
    Hideshima T; Okada N; Okada H
    Immunology; 1990 Mar; 69(3):396-401. PubMed ID: 1690178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.